Lung cancer with lung tissue array (2015 WHOclassification), 2 cores per case, 2 serial sections, divided into two identical 24 core arrays. Pathology grade, TNM Classification, and clinical-stage information available. Replacing LC243.
- 12 cases of squamous cell carcinoma
- 6 cases of adenocarcinoma
- 6 cases of normal lung tissue
Price
$165.00
Catalogue No | RLC-243a |
Description | Lung cancer with lung tissue array (2015 WHOclassification), 2 cores per case, 2 serial sections, divided into two identical 24 core arrays. Pathology grade, TNM Classification, and clinical-stage information available. Replacing LC243. |
Species | Human |
Fixative | Formalin |
Total Cases | 24 |
Total Cores | 48 |
Core Diameter | 2 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 68 | M | Lung | Keratinizing squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant |
2 | A2 | 45 | M | Lung | Squamous cell carcinoma (chronic pneumonia) | * | T3N0M0 | IIB | Malignant |
3 | A3 | 56 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant |
4 | A4 | 57 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
5 | A5 | 50 | M | Lung | Keratinizing squamous cell carcinoma with necrosis | 2 | T2aN0M0 | IB | Malignant |
6 | A6 | 65 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T2aN1M0 | IIA | Malignant |
7 | A7 | 68 | M | Lung | Keratinizing squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant |
8 | A8 | 45 | M | Lung | Squamous cell carcinoma (chronic pneumonia) | * | T3N0M0 | IIB | Malignant |
9 | A9 | 56 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant |
10 | A10 | 57 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
11 | A11 | 50 | M | Lung | Keratinizing squamous cell carcinoma with necrosis | 2 | T2aN0M0 | IB | Malignant |
12 | A12 | 65 | M | Lung | Keratinizing squamous cell carcinoma | 2 | T2aN1M0 | IIA | Malignant |
13 | B1 | 61 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant |
14 | B2 | 68 | M | Lung | Non-keratinizing squamous cell carcinoma with necrosis | 3 | T3N0M0 | IIB | Malignant |
15 | B3 | 59 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant |
16 | B4 | 66 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
17 | B5 | 66 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
18 | B6 | 49 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
19 | B7 | 61 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant |
20 | B8 | 68 | M | Lung | Non-keratinizing squamous cell carcinoma with necrosis | 3 | T3N0M0 | IIB | Malignant |
21 | B9 | 59 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant |
22 | B10 | 66 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
23 | B11 | 66 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
24 | B12 | 49 | M | Lung | Non-keratinizing squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
25 | C1 | 60 | F | Lung | Acinar adenocarcinoma | 1 | T3N1M0 | IIIA | Malignant |
26 | C2 | 57 | F | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
27 | C3 | 48 | M | Lung | Mucinous adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
28 | C4 | 42 | M | Lung | Acinar adenocarcinoma | 1 | T2aN0M0 | IB | Malignant |
29 | C5 | 48 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
30 | C6 | 56 | M | Lung | Micropapillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
31 | C7 | 60 | F | Lung | Acinar adenocarcinoma | 1 | T3N1M0 | IIIA | Malignant |
32 | C8 | 57 | F | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
33 | C9 | 48 | M | Lung | Mucinous adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
34 | C10 | 42 | M | Lung | Acinar adenocarcinoma | 1 | T2aN0M0 | IB | Malignant |
35 | C11 | 48 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
36 | C12 | 56 | M | Lung | Micropapillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
37 | D1 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
38 | D2 | 15 | F | Lung | Normal Lung Tissue | - | - | - | Normal |
39 | D3 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
40 | D4 | 22 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
41 | D5 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
42 | D6 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
43 | D7 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
44 | D8 | 15 | F | Lung | Normal Lung Tissue | - | - | - | Normal |
45 | D9 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
46 | D10 | 22 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
47 | D11 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
48 | D12 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |